I. - Basic information

I.1 - Surname

Hatok

I.2 - Name

Jozef

I.3 - Degrees

I/II/III

I.4 - Year of birth

14.11.1978

I.5 - Name of the workplace

Department of Medical Biochemistry, Jessenius Faculty of Medicine CU in Martin

I.6 - Address of the workplace

Mala HOra 4D, 036 01 Martin, Slovakia

I.7 - Position

assoc. professor

I.8 - E-mail address

jozef.hatok@uniba.sk

I.10 - Name of the study field in which a person works at the university

Medical, clinical and pharmaceutical biochemistry

I.11 - ORCID iD

0000-0002-3994-1436

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.a - Name of the university or institution

Pavol Jozef Šafárik University - Faculty of Science

II.b - Year

2001

II.c - Study field and programme

Chemistry

II.2 - Second degree of higher education

II.a - Name of the university or institution

Pavol Jozef Šafárik University - Faculty of Science

II.b - Year

2003

II.c - Study field and programme

Chemistry - Biochemistry

II.3 - Third degree of higher education

II.a - Name of the university or institution

Comenius University - Jessenius Faculty of Medicine

II.b - Year

2007

II.c - Study field and programme

Biochemistry

II.4 - Associate professor

II.a - Name of the university or institution

Comenius University - Jessenius Faculty of Medicine

II.b - Year

2016

II.c - Study field and programme

Medical, clinical and pharmaceutical biochemistry

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
University teacher - assoc. professor	Department of Medical Biochemistry, Jessenius Faculty of Medicine CU in Martin	2017 -
University teacher - assistant	Department of Medical Biochemistry, Jessenius Faculty of Medicine CU in Martin	2008 - 2017
Researcher	Department of Medical Biochemistry, Jessenius Faculty of Medicine CU in Martin	01/2007 - 08/2008

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree
Medical chemistry	General medicine	II.
Medical biochemistry	General medicine	II.
Chemistry for dental medicine	Dental medicine	II.
Chemistry for non-medical disciplines	Non-medical programme	I.

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.3.a - Name of the field of habilitation procedure and inaugural procedure	V.3.b - Study field to which it is assigned
Medical, clinical and farmaceutical biochemistry

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.4.2 - Number of defended theses

V.4.c - Dissertation (third degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree	V.5.d - Field of study
		III.	Medical, clinical and farmaceutical biochemistry

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

267

VI.1.b - Over the last six years

123

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

664

VI.1.b - Over the last six years

431

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

530

VI.1.b - Over the last six years

366

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

DNA Methylation Machinery in the Endometrium and Endometrial Cancer. Caplakova V, Babusikova E, Blahovcova E, Balharek T, Zelieskova M, Hatok J. Anticancer Res. 2016 Sep;36(9):4407-20. doi: 10.21873/anticanres.10984.

In vitro assays for the evaluation of drug resistance in tumor cells. Hatok J, Babusikova E, Matakova T, Mistuna D, Dobrota D, Racay P. Clin Exp Med. 2009 Mar;9(1):1-7. doi: 10.1007/s10238-008-0011-3. Epub 2008 Sep 26.

Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells. Majercikova Z, Dibdiakova K, Gala M, Horvath D, Murin R, Zoldak G, Hatok J. Int J Mol Sci. 2022 Sep 17;23(18):10883. doi: 10.3390/ijms231810883.

The effect of temozolomide on apoptosis-related gene expression changes in glioblastoma cells. Vidomanova E, Majercikova Z, Dibdiakova K, Pilchova I, Racay P, Hatok J. Bratisl Lek Listy. 2022;123(4):236-243. doi: 10.4149/BLL_2022_038.

DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients. Fialkova V, Vidomanova E, Balharek T, Marcinek J, Kudela E, Hanysova S, Visnovsky J, Dobrota D, Hatok J. Gen Physiol Biophys. 2017 Dec;36(5):521-529. doi: 10.4149/gpb_2017032.

VI.3 - The most significant research/artistic/other outputs over the last six years

Quantitative profiling of genes associated with cancer pathways in brain tumors. Majerčíková Z, Dibdiaková K, Galanda M, Galanda T, Richterová R, Kolarovszki B, Račay P, Hatok J. Klin Onkol. 2023 Spring;36(3):224-233. doi: 10.48095/ccko2023224.

Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients. Dibdiakova K, Svec A, Majercikova Z, Adamik M, Grendar M, Vana J, Ferko A, Hatok J. Mol Clin Oncol. 2022 Feb;16(2):41. doi: 10.3892/mco.2021.2475. Epub 2021 Dec 21.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Citated 27:

Hatok, Jozef (aut) [UKOLJ111] (30%) - Žúbor, Pavol (aut) (25%) - Galo, Silvester (aut) (10%) - Kirschnerová, Renáta (aut) (10%) - Dobrota, Dušan (aut) [UKOLJ111] (5%) - Danko, Ján (aut) [UKOLJ150] (5%) - Račay, Peter (aut) [UKOLJ111] (15%):Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis

In: Gynecological Endocrinology. - Roč. 27, č. 5 (2011), s. 331-336. - ISSN 0951-3590

URL: http://www.tandfonline.com/doi/full/10.3109/09513590.2010.491925

Citated 53:

Hatok, Jozef (aut) [UKOLJ111] (40%) - Babušíková, Eva (aut) [UKOLJ111] (10%) - Matáková, Tatiana (aut) [UKOLJ111] (5%) - Mištuna, Dušan (aut) (5%) - Dobrota, Dušan (aut) [UKOLJ111] (5%) - Račay, Peter (aut) [UKOLJ111] (35%): In vitro assaysfor the evaluation of drug resistance in tumor cells

Literatúra. 42

In: Clinical and Experimental Medicine. - Roč. 9, č. 1 (2009), s. 1-7. - ISSN 1591-8890

URL: https://link.springer.com/article/10.1007/s10238-008-0011-3

Citated 15:

Fialková, Veronika (aut) (40%) - Vidomanová, Eva (aut) (15%) - Balhárek, Tomáš (aut) [UKOLJ251] (12%) - Marcinek, Juraj (aut) [UKOLJ] (5%) - Kúdela, Erik (aut) [UKOLJ150] (5%) - Hanyšová, Sandra (aut) (2%) - Višňovský, Jozef (aut) [UKOLJ150](3%) - Dobrota, Dušan (aut) [UKOLJ111] (3%) - Hatok, Jozef (aut) [KAUT] [UKOLJ111] (15%): DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients

In: General Physiology and Biophysics. - Roč. 36, č. 5 (2017), s. 521-529. - ISSN 0231-5882

180 Lekárske, farmaceutické a nelekárske zdravotnícke vedy

Registrované v:

WOS CC Web of Science Core Collection

Indikátor časopisu:

IF (JCR) 2017=1,479

wos-jcr (Q4 [Biochemistry&molecular biology])

wos-jcr (Q4 [Biophysics]])

Citated 34:

In: Gynecological Endocrinology. - Roč. 27, č. 5 (2011), s. 331-336. - ISSN 0951-3590

URL: http://www.tandfonline.com/doi/full/10.3109/09513590.2010.491925

Registrované v:

SCOPUS SCOPUS

Indikátor časopisu:

IF (JCR) 2011=1,581

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

Principal responsible APVV-0224-12:

Detection and modulation of intrinsic apoptotic pathway to reverse chemoresistance in tumour cells.

Principal responsible APVV-18-0088

Complete molecular characterization of heterogeneity and signaling of glial cells in the tumorigenesis process.

Principal responsible VEGA-1/0279/10:

MONITORING THE EXPRESSION PROFILE OF GENES RESPONSIBLE FOR RESISTANCE IN BREAST CANCER CELLS

Deputy Head of VEGA 1/0234/12:

Analysis of gene expression profile in breast cancer to determine the risk of disease and targeted personalized treatment

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2023-09-29

Name and surname:	doc. RNDr. Jozef Hatok, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava